Patient Advocate Fellowship

The DIA Patient Advocate Fellowship Programme is designed to do the following:

Develop, strengthen, and support patient collaborations with policy makers, industry representatives, public health authorities, academia, and other healthcare stakeholders.
Improve alliances between patient groups and other healthcare stakeholders
Increase knowledge and understanding of issues central to the promotion of patient-centred healthcare, biomedical research, and drug development
Provide a forum for sharing best practices, stimulating cooperation, and facilitating a two-way dialogue across the entire global healthcare community.
Enhance the capacity of patient advocates to respond to changes in drug development and health care delivery
Integrate the patient voice by attending EuroMeeting program offerings, roundtable discussions, and networking events

Who should apply?

Applicant should be affiliated with a patient organisation
Demonstrated track record of education and/or advocacy activities
Patient engagement in or be familiar with activities related to clinical trials, drug development, HTA, regulatory affairs
The business language of the conference is English. Patient Fellows must be able to understand scientific content in English and network with other attendees with ease

The deadline for applications is: 10 January 2015Applicants will be notified of acceptance by 13 February 2015